Aida Pharmaceuticals, Inc.
AIDA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.1K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8,100.00 |
|---|---|
| Enterprise Value | $33.02 Million |
| Earnings per Share | $0.1 |
| Beta | 3.84 |
| Outstanding Shares | 27,000,000 |
Return
| Return on Equity | -22.87% |
|---|---|
| Return on Assets | -2.83% |
| Return on Invested Capital | 0.00% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.81 |
| Enterprise Value to EBIT | 29066.17 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 1.25 |
| Debt to Equity | 4.51 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aida Pharmaceuticals, Inc.
450 employees
CEO: Biao Jin
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trial...